P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

March 2009

Features

Administration of Proton Pump Inhibitors In Patients Requiring Enteral Nutrition

Patients who need enteral nutrition may also require PPIs for acid suppression. The currently available and most widely prescribed PPIs are reviewed, along with their routes of delivery in nasogastric, gastrostomy, and jejunal feeding tubes.
Terri M. Wensel, PharmD

Commentary

Health Care Blog Watch

Emerging Trends in the Blogosphere
Even pharmaceutical companies, which have long shied away from blogging on the Internet, understand that the conventional static Web site is just not good enough any more. Will future pharma bloggers be able to incorporate the real-time engagement and transparency that are needed?
Miriam Reisman

Meeting Highlights

FDA Advisory Committee Meeting on Prasugrel for Acute Coronary Syndromes

If approved by the FDA, the platelet inhibitor prasugrel will be a first-in-its-class competitor of clopidogrel (Plavix). The new drug is designed to reduce the risk of nonfatal myocardial infarction, nonfatal stroke, and death from cardiovascular disease, but bleeding and the risk of neoplasms can result.
Walter Alexander

Pharmaceutical Approval Update

Topics include milnacipran (Savella) tablets for fibromyalgia, calcitriol ointment (Vectical) for plaque psoriasis, and degarelix subcutaneous injection, a hormone for treating advanced prostate cancer.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

Evidence-Informed Case Rates

David B. Nash, MD, MBA, discusses evidence-based case rates, the building blocks of a new payment model that aims to support a patient-centered health environment.
David B. Nash, MD, MBA

Medication Errors

An Exhausted Workforce Increases the Risk of Errors

Matthew Grissinger, RPh, FASCP, recommends rest periods, off-duty time, naps, meal breaks, and other safety practices to prevent fatigue in health care workers, thereby minimizing the potential for mistakes on the job.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

New FDA Guidance on Off-Label Promotion Falls Short for Everyone

Stephen Barlas discusses how the FDA under the Obama administration might deal with off-label drug promotion for unapproved uses.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From ATryn to Tindamax, P&T presents the latest information about FDA approvals, indications, recalls, and updates.

Drug Forecast

Rilonacept (Arcalyst), an Interleukin-1 Trap for the Treatment of Cryopyrin-Associated Periodic Syndromes

Drs. Kapur and Bonk review rilonacept (Arcalyst) for treating cryopyrin-associated periodic syndromes.
Saloni Kapur, PharmD, MPA, and Mary Ellen Bonk, PharmD